Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joëlle Micallef

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Therapie|December 19, 2016
[Acute psychiatric symptoms during methylphenidate intravenous injections: A case report]Fabrice Vérité, Joëlle Micallef
Therapie|March 12, 2020
Orphan drug designation in Europe: A booster for the research and development of drugs in rare diseasesJoëlle Micallef, Olivier Blin
Therapie|June 15, 2016
[Twenty-five years of the French Addictovigilance Network (FAN)]Joëlle Micallef, Michel Mallaret
Fundamental & Clinical Pharmacology|August 6, 2017
Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacologyJoëlle Micallef, Pierre Boutouyrie, Olivier Blin
Therapie|July 10, 2016
Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs?Joëlle Micallef-Roll, Maryse Lapeyre-Mestre,
Therapie|March 2, 2020
Patients' organizations in rare diseases and involvement in drug information: Illustrations with LMC France, the French Association of Chronic Myeloid leukemiaMina Daban, Clémence Lacroix, Joëlle Micallef
Therapie|February 28, 2022
[Pharmacology of cannabidiol: Red flags, consequences and risks in humans]Joëlle Micallef, Anne Batisse, Bruno Revol
Therapie|March 22, 2007
[Prescription switch studies: objectives, methods and limits]Vincent Pradel, Joëlle Micallef, Olivier Blin
Therapie|December 23, 2009
Second meeting of the French CEIP (Centres d'Evaluation et d'Information sur la Pharmacodépendance). Part I: how to evaluate and prevent the abuse and dependence on hypnotic/anxiolytic drugs?Joëlle Micallef-Roll, Maryse Lapeyre-Mestre,
Therapie|March 20, 2025
[Deleterious impact of a non-steroidal anti-inflammatory taken for fever or acute pain in case of streptococcal infection]Annie-Pierre Jonville-Bera, Joëlle Micallef
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Therapie|December 19, 2016
[Acute psychiatric symptoms during methylphenidate intravenous injections: A case report]Fabrice Vérité, Joëlle Micallef
Therapie|March 12, 2020
Orphan drug designation in Europe: A booster for the research and development of drugs in rare diseasesJoëlle Micallef, Olivier Blin
Therapie|June 15, 2016
[Twenty-five years of the French Addictovigilance Network (FAN)]Joëlle Micallef, Michel Mallaret
Fundamental & Clinical Pharmacology|August 6, 2017
Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacologyJoëlle Micallef, Pierre Boutouyrie, Olivier Blin
Therapie|July 10, 2016
Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs?Joëlle Micallef-Roll, Maryse Lapeyre-Mestre,
Therapie|March 2, 2020
Patients' organizations in rare diseases and involvement in drug information: Illustrations with LMC France, the French Association of Chronic Myeloid leukemiaMina Daban, Clémence Lacroix, Joëlle Micallef
Therapie|February 28, 2022
[Pharmacology of cannabidiol: Red flags, consequences and risks in humans]Joëlle Micallef, Anne Batisse, Bruno Revol
Therapie|March 22, 2007
[Prescription switch studies: objectives, methods and limits]Vincent Pradel, Joëlle Micallef, Olivier Blin
Therapie|December 23, 2009
Second meeting of the French CEIP (Centres d'Evaluation et d'Information sur la Pharmacodépendance). Part I: how to evaluate and prevent the abuse and dependence on hypnotic/anxiolytic drugs?Joëlle Micallef-Roll, Maryse Lapeyre-Mestre,
Therapie|March 20, 2025
[Deleterious impact of a non-steroidal anti-inflammatory taken for fever or acute pain in case of streptococcal infection]Annie-Pierre Jonville-Bera, Joëlle Micallef
Pageof 17